Oriol de Fàbregues

2.2k total citations
27 papers, 583 citations indexed

About

Oriol de Fàbregues is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Oriol de Fàbregues has authored 27 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 7 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Oriol de Fàbregues's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (13 papers) and Restless Legs Syndrome Research (6 papers). Oriol de Fàbregues is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (13 papers) and Restless Legs Syndrome Research (6 papers). Oriol de Fàbregues collaborates with scholars based in Spain, Palestinian Territory and Netherlands. Oriol de Fàbregues's co-authors include Jorge Hernández‐Vara, Francesc Valldeoriola, Jordi Mesa, Ana Cantón, Víctor Puente, A Codina, Rafael Simó, Mar Tintoré, Matilde Calopa and Claustre Pont‐Sunyer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Oriol de Fàbregues

27 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oriol de Fàbregues Spain 12 493 136 93 68 64 27 583
Subhashie Wijemanne United States 11 293 0.6× 85 0.6× 140 1.5× 40 0.6× 34 0.5× 17 467
Ana Lúcia Zuma de Rosso Brazil 14 372 0.8× 40 0.3× 123 1.3× 37 0.5× 55 0.9× 48 533
Idoia Rouco Spain 8 477 1.0× 179 1.3× 105 1.1× 17 0.3× 26 0.4× 12 574
Adriana Di Santo Germany 9 436 0.9× 144 1.1× 127 1.4× 10 0.1× 57 0.9× 9 526
L Manfredi Italy 9 424 0.9× 97 0.7× 86 0.9× 13 0.2× 35 0.5× 20 505
Marlene Alonso-Juárez Mexico 12 218 0.4× 36 0.3× 81 0.9× 45 0.7× 71 1.1× 34 433
Ainhi D. Ha Australia 13 476 1.0× 68 0.5× 221 2.4× 19 0.3× 155 2.4× 23 656
Chizoba C. Umeh United States 10 215 0.4× 33 0.2× 76 0.8× 20 0.3× 40 0.6× 18 329
M. J. Martí Spain 11 333 0.7× 93 0.7× 96 1.0× 12 0.2× 72 1.1× 14 462
Michela Zini Italy 13 344 0.7× 49 0.4× 134 1.4× 9 0.1× 79 1.2× 18 512

Countries citing papers authored by Oriol de Fàbregues

Since Specialization
Citations

This map shows the geographic impact of Oriol de Fàbregues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol de Fàbregues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol de Fàbregues more than expected).

Fields of papers citing papers by Oriol de Fàbregues

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oriol de Fàbregues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol de Fàbregues. The network helps show where Oriol de Fàbregues may publish in the future.

Co-authorship network of co-authors of Oriol de Fàbregues

This figure shows the co-authorship network connecting the top 25 collaborators of Oriol de Fàbregues. A scholar is included among the top collaborators of Oriol de Fàbregues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oriol de Fàbregues. Oriol de Fàbregues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fàbregues, Oriol de, et al.. (2025). Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases. Frontiers in Immunology. 16. 1599303–1599303. 1 indexed citations
2.
Gámez, Josep, Francesc Carmona, Carles Lorenzo‐Bosquet, et al.. (2024). Myasthenia gravis concurrent with Parkinson’s disease in a Spanish cohort. Causation or correlation?. Neurological Sciences. 45(7). 3183–3189. 3 indexed citations
3.
Fàbregues, Oriol de, et al.. (2023). Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?. Neurobiology of Disease. 187. 106308–106308. 4 indexed citations
4.
Kulisevsky, Jaime, Helena Bejr‐Kasem, Saül Martínez‐Horta, et al.. (2020). Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa. Journal of Neurology. 267(11). 3400–3410. 8 indexed citations
5.
Fàbregues, Oriol de, et al.. (2020). Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain and Behavior. 10(5). e01596–e01596. 9 indexed citations
6.
Catalán, María José, Angelo Antonini, Matilde Calopa, et al.. (2017). Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?. eNeurologicalSci. 8. 44–53. 10 indexed citations
7.
Krüger, Rejko, Paul Lingor, Triantafyllos Doskas, et al.. (2017). An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients. Advances in Therapy. 34(7). 1741–1752. 25 indexed citations
8.
Sáez‐Francàs, Naia, et al.. (2016). Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease. SHILAP Revista de lepidopterología. 31(4). 231–238. 28 indexed citations
9.
Sáez‐Francàs, Naia, et al.. (2015). Factores clínicos y psicopatológicos asociados a los trastornos del control de impulsos en la enfermedad de Parkinson. Neurología. 31(4). 231–238. 23 indexed citations
10.
Vilas, Dolores, Lourdes Ispierto, Ramiro Álvarez, et al.. (2015). Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism & Related Disorders. 21(10). 1170–1176. 28 indexed citations
11.
Pont‐Sunyer, Claustre, Álex Iranzo, Carles Gaig, et al.. (2015). Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers. PLoS ONE. 10(7). e0132368–e0132368. 66 indexed citations
12.
Weller, Claudia M, Nadine Pelzer, Boukje de Vries, et al.. (2014). Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia. 34(13). 1062–1069. 24 indexed citations
13.
Vries, Boukje de, et al.. (2013). Novel SCN1A mutation in the IFMT motif of the α1 subunit of the voltage-gated NaV1.1 channel causing familial hemiplegic migraine. The Journal of Headache and Pain. 14(S1). 1 indexed citations
14.
Gámez, Josep, Carles Lorenzo‐Bosquet, Gemma Cuberas‐Borrós, et al.. (2013). Progressive Presynaptic Dopaminergic Deterioration in Huntington Disease. Clinical Nuclear Medicine. 39(3). e227–e228. 7 indexed citations
15.
Botta‐Orfila, Teresa, Mario Ezquerra, Pau Pástor, et al.. (2012). Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants. Journal of Molecular Neuroscience. 48(1). 245–247. 27 indexed citations
16.
Santos‐García, Diego, Raúl de la Fuente‐Fernández, Francesc Valldeoriola, et al.. (2012). Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert. Journal of Neurology. 259(8). 1668–1672. 44 indexed citations
17.
Rodríguez‐Oroz, María, Concepción Marín, & Oriol de Fàbregues. (2011). Continuous Dopaminergic Stimulation. The Neurologist. 17(6 Suppl 1). S30–S37. 11 indexed citations
18.
Puente, Víctor, Oriol de Fàbregues, Clara Oliveras, et al.. (2009). Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life. Parkinsonism & Related Disorders. 16(3). 218–221. 45 indexed citations
19.
Cantón, Ana, Oriol de Fàbregues, Mar Tintoré, et al.. (2000). Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition?. Journal of the Neurological Sciences. 176(1). 65–69. 92 indexed citations
20.
Queralt, R., Oriol de Fàbregues, M. Gené, et al.. (1993). Direct Sequencing of the Human Protamine P1 Gene and Application in Forensic Medicine. Journal of Forensic Sciences. 38(6). 1491–1501. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subhashie Wijemanne Breakdown of academic impact, for papers by Ana Lúcia Zuma de Rosso Breakdown of academic impact, for papers by Idoia Rouco Breakdown of academic impact, for papers by Adriana Di Santo Breakdown of academic impact, for papers by L Manfredi Breakdown of academic impact, for papers by Marlene Alonso-Juárez Breakdown of academic impact, for papers by Ainhi D. Ha Breakdown of academic impact, for papers by Chizoba C. Umeh Breakdown of academic impact, for papers by M. J. Martí Breakdown of academic impact, for papers by Michela Zini
Rankless by CCL
2026